Q4 2020 Oncolytics Biotech Inc Earnings Call Transcript
Good morning, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Jon Patton, Director of Investor Relations and Communication. Please go ahead.
Thank you, operator. Good morning, everyone, and welcome to Oncolytics Biotech's Fourth quarter and Full Year 2020 Conference Call. Earlier today, Oncolytics issued a press release providing financial results and corporate updates for the fourth quarter and full year 2020. A replay of today's call will be available on the Events and Presentations section of the Oncolytics website approximately 2 hours after its completion. After remarks from company management, we will open the call for Q&A.
As a reminder, various remarks made during this call contain certain forward-looking statements relating to the company's business prospects and the development
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |